- United States
- /
- Capital Markets
- /
- NYSE:AMP
Is the Addition of Harpland Financial Influencing Ameriprise's Adviser Growth Strategy (AMP)?
Reviewed by Sasha Jovanovic
- Harpland Financial Management, a Houston-based advisory practice with over US$160 million in client assets, recently joined Ameriprise Financial’s branch network from Wells Fargo Clearing Services, as announced by the practice itself.
- This move highlights Ameriprise’s efforts to enhance its adviser network by investing in advanced technology, integrated planning tools, and expanded service capabilities for client-focused advice delivery.
- To understand how the addition of experienced advisers and notable client assets may influence Ameriprise’s growth outlook, we’ll explore the implications for its investment narrative.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Ameriprise Financial Investment Narrative Recap
To be a shareholder in Ameriprise Financial, you need to believe in the company's ability to expand its adviser network and grow client assets through technology and service enhancements. The addition of Harpland Financial Management is positive for adviser expansion but does not materially change the most important short-term catalyst: continued investment in adviser technology to improve productivity. The key risk remains increased competition in adviser recruiting, which could pressure margins if costs rise. Among the recent announcements, the August 2025 transition of ChoiceOne Bank’s investment program to Ameriprise Financial Institution Group stands out for its relevance. Like the Harpland Financial addition, this move demonstrates Ameriprise’s appeal to outside advisory teams and banks, supporting its growth catalysts focused on recruitment, retention, and technology-driven adviser productivity improvements. However, investors should also be aware that rising costs to secure top adviser talent could...
Read the full narrative on Ameriprise Financial (it's free!)
Ameriprise Financial's narrative projects $20.7 billion in revenue and $4.0 billion in earnings by 2028. This requires 4.4% yearly revenue growth and an $0.8 billion increase in earnings from the current $3.2 billion.
Uncover how Ameriprise Financial's forecasts yield a $533.18 fair value, a 17% upside to its current price.
Exploring Other Perspectives
Fair value estimates from five Simply Wall St Community members span from US$487.83 to over US$1,287,998.62, highlighting vastly different views. As adviser recruitment heats up, these perspectives show just how much your outlook on adviser productivity can shape expectations about Ameriprise’s future performance.
Explore 5 other fair value estimates on Ameriprise Financial - why the stock might be a potential multi-bagger!
Build Your Own Ameriprise Financial Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Ameriprise Financial research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Ameriprise Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ameriprise Financial's overall financial health at a glance.
Contemplating Other Strategies?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:AMP
Ameriprise Financial
Operates as a diversified financial services company in the United States and internationally.
Outstanding track record, undervalued and pays a dividend.
Similar Companies
Market Insights
Community Narratives


Recently Updated Narratives
Constellation Energy Dividends and Growth
CoreWeave's Revenue Expected to Rocket 77.88% in 5-Year Forecast
Bisalloy Steel Group will shine with a projected profit margin increase of 12.8%
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
